FDA Panel Backs First-Of-A-Kind COVID-19 Pill From Merck

Published November 30, 2021 534 Views

Rumble An FDA advisory panel has backed Merck's experimental antiviral medication to treat COVID.

BREAKING: Rumble to Combine with NASDAQ listed CFVI